Which trial do we need? Comparison of 7 versus 14 days of antibiotic therapy for ventilator-associated pneumonia due to highly resistant gram-negative bacteria

被引：1
|
作者：
Tleyjeh, Imad M. [1 ,2 ,3 ,4 ,5 ]
机构：
[1] King Fahad Med City, Dept Med Specialties, Infect Dis Sect, Riyadh, Saudi Arabia
[2] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia
[3] Mayo Clin, Coll Med & Sci, Div Publ Hlth Infect Dis & Occupat Med, Rochester, MN USA
[4] Mayo Clin, Coll Med & Sci, Div Epidemiol, Rochester, MN USA
[5] King Fahd Med City, Sect Infect Dis, POB 59046, Riyadh 11525, Saudi Arabia
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2023年 / 29卷 / 09期
关键词：
Drug resistance; Gram-negative bacteria; Pneumonia; Short-course therapy; Ventilator; Trial design considerations; INFECTIOUS-DISEASES SOCIETY; DURATION; AMERICA;
D O I：
10.1016/j.cmi.2023.04.018
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1114 / 1116
页数：3
相关论文
共 50 条
  • [41] Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical Trial: Comparison of 8 versus 15 Days of Antibiotic Treatment
    Capellier, Gilles
    Mockly, Helene
    Charpentier, Claire
    Annane, Djillali
    Blasco, Gilles
    Desmettre, Thibault
    Roch, Antoine
    Faisy, Christophe
    Cousson, Joel
    Limat, Samuel
    Mercier, Mariette
    Papazian, Laurent
    PLOS ONE, 2012, 7 (08):
  • [42] ORAL CAVITY COLONIZATION WITH MULTIDRUG-RESISTANT GRAM-NEGATIVE BACTERIA AFTER PREOPERATIVE PROPHYLACTIC USE OF ANTIBIOTICS AS A RISK FACTOR FOR VENTILATOR-ASSOCIATED PNEUMONIA
    Bratic, Vesna
    Lukic, Anita
    Bedenic, Branka
    Bjelanovic, Ivana
    Bevanda, Mateo
    Mihaljevic, Slobodan
    Verzak, Zeljko
    PSYCHIATRIA DANUBINA, 2021, 33 : S247 - S254
  • [43] Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin (vol 46, pg 766, 2020)
    Rouby, J. J.
    Sole-Lleonart, C.
    Rello, J.
    INTENSIVE CARE MEDICINE, 2020, 46 (04) : 832 - 832
  • [44] Correction to: Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial
    Adrien Bouglé
    Sophie Tuffet
    Laura Federici
    Marc Leone
    Antoine Monsel
    Thomas Dessalle
    Julien Amour
    Claire Dahyot-Fizelier
    François Barbier
    Charles-Edouard Luyt
    Olivier Langeron
    Bernard Cholley
    Julien Pottecher
    Tarik Hissem
    Jean-Yves Lefrant
    Benoit Veber
    Matthieu Legrand
    Alexandre Demoule
    Pierre Kalfon
    Jean-Michel Constantin
    Alexandra Rousseau
    Tabassome Simon
    Arnaud Foucrier
    Intensive Care Medicine, 2022, 48 : 992 - 994
  • [45] Empiric, Broad-Spectrum Antibiotic Therapy with an Aggressive De-Escalation Strategy Does Not Induce Gram-Negative Pathogen Resistance in Ventilator-Associated Pneumonia
    Hibbard, Michael L.
    Kopelman, Tammy R.
    O'Neill, Patrick J.
    Maly, Tyler J.
    Matthews, Marc R.
    Cox, Jordy C.
    Vail, Sydney J.
    Quan, Asia N.
    Drachman, David A.
    SURGICAL INFECTIONS, 2010, 11 (05) : 427 - 432
  • [46] Single-drug versus combination antimicrobial therapy in critically ill patients with hospital-acquired pneumonia and ventilator-associated pneumonia due to Gram-negative pathogens: a multicenter retrospective cohort study
    François Barbier
    Claire Dupuis
    Niccolò Buetti
    Carole Schwebel
    Élie Azoulay
    Laurent Argaud
    Yves Cohen
    Vivien Hong Tuan Ha
    Marc Gainnier
    Shidasp Siami
    Jean-Marie Forel
    Christophe Adrie
    Étienne de Montmollin
    Jean Reignier
    Stéphane Ruckly
    Jean-Ralph Zahar
    Jean-François Timsit
    Critical Care, 28
  • [47] Single-drug versus combination antimicrobial therapy in critically ill patients with hospital-acquired pneumonia and ventilator-associated pneumonia due to Gram-negative pathogens: a multicenter retrospective cohort study
    Barbier, Francois
    Dupuis, Claire
    Buetti, Niccolo
    Schwebel, Carole
    Azoulay, Elie
    Argaud, Laurent
    Cohen, Yves
    Hong Tuan Ha, Vivien
    Gainnier, Marc
    Siami, Shidasp
    Forel, Jean-Marie
    Adrie, Christophe
    de Montmollin, Etienne
    Reignier, Jean
    Ruckly, Stephane
    Zahar, Jean-Ralph
    Timsit, Jean-Francois
    CRITICAL CARE, 2024, 28 (01)
  • [48] Ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacilli in an intensive care unit without carbapenemase-producing Enterobacteriaceae or epidemic Acinetobacter baumannii
    Soubirou, Jean-Francois
    Gault, Nathalie
    Alfaiate, Toni
    Lolom, Isabelle
    Tubach, Florence
    Andremont, Antoine
    Lucet, Jean-Christophe
    Wolff, Michel
    Barbier, Francois
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2014, 46 (03) : 215 - 220
  • [49] Comparison of the clinical efficacy and toxicity of nebulized polymyxin monotherapy and combined intravenous and nebulized polymyxin for the treatment of ventilator-associated pneumonia caused by carbapenem-resistant gram-negative bacteria: a retrospective cohort study
    Wu, Zhenping
    Zhang, Siying
    Cao, Yelin
    Wang, Qiyu
    Sun, Keyuan
    Zheng, Xia
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [50] Ceftazidime/Avibactam in Ventilator-Associated Pneumonia Due to Difficult-to-Treat Non-Fermenter Gram-Negative Bacteria in COVID-19 Patients: A Case Series and Review of the Literature
    Burastero, Giulia Jole
    Orlando, Gabriella
    Santoro, Antonella
    Menozzi, Marianna
    Franceschini, Erica
    Bedini, Andrea
    Cervo, Adriana
    Faltoni, Matteo
    Bacca, Erica
    Biagioni, Emanuela
    Coloretti, Irene
    Melegari, Gabriele
    Maccieri, Jessica
    Busani, Stefano
    Bertellini, Elisabetta
    Girardis, Massimo
    Ferrarini, Giulia
    Rofrano, Laura
    Sarti, Mario
    Mussini, Cristina
    Meschiari, Marianna
    ANTIBIOTICS-BASEL, 2022, 11 (08):
12345